Skip to main content
. Author manuscript; available in PMC: 2015 Sep 3.
Published in final edited form as: Thorax. 2014 Jan 24;69(6):565–573. doi: 10.1136/thoraxjnl-2013-204605

Fig 2. Limited 1018 ISS treatments induce lasting suppression of airway Th2 responses.

Fig 2

A, Tx Protocol 2: Groups similar to Tx Protocol 1 except that 1018 ISS was given for 12 weeks, followed by either 4 (B) or 13 (C) weekly RW only exposures. BALF cytokines, eosinophils, and lung gene expression shown (mean ± SEM, 5 mice/group). *P<0.05, **P<0.01, and ***P<0.0001, compared to RW. 1 representative experiment of 4 shown.